EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY-NC 4.0

Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study

Dewei Li iD, Shuting Yang, Ling Zhang, Lingling Dong, Yueeryeti Sailai, Limin Yao, Chengyu Jin, Xuemei Wei

Technology in Cancer Research & Treatment · 2026-07 · 25

DOI: 10.1177/15330338261470635 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 31.07.2026. Verfasst von Dewei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Respiratory and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Metabolomics, Biomarkers, Tumor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regional Collaborative Innovation Special Project - Science and Technology Aid Xinjiang Program, The National Key Clinical Specialty of the People’s Hospital of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung cancer is a malignant tumor with high global incidence and mortality. Early screening and diagnosis can substantially extend patient survival, yet achieving this remains a challenging objective.

Methods

We collected tissue and plasma samples from patients with benign pulmonary nodules and non-small cell lung cancer (NSCLC). Exhaled breath condensate (EBC) samples were obtained from these patients using a breath condenser. Differential metabolites were identified in samples from 22 NSCLC patients and 20 benign controls by means of ultra-performance liquid chromatography–high resolution mass spectrometry–based untargeted metabolomics.

Results

Several differential metabolites overlapped between plasma and tissue samples. Further analysis indicated that the differential metabolites from all three sample types participated in central carbon metabolism in cancer, protein digestion and absorption, and aminoacyl-tRNA biosynthesis. ROC curve analysis of plasma and tissue metabolites showed that each of the top 10 upregulated and downregulated metabolites yielded AUC values greater than 0.8. In EBC, only 29 differential metabolites were detected. Among these, lysine, acetildenafil, and 1-(cyclohexylmethyl) proline may be involved in the progression of NSCLC.

Conclusion

This study identified distinctive metabolic markers in plasma, tissue, and EBC from NSCLC patients. However, the purpose of this observational study was merely exploratory, rather than to use these differential metabolites as a diagnostic test for non-small cell lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMetabolomicsBiomarkers, TumorMetabolomeHumansFemaleCase-Control StudiesMaleBreath TestsMiddle AgedAgedExhalationROC Curve

Stichwörter der Autor:innen

exhaled breath condensate (EBC)non-small cell lung cancer (NSCLC)plasmatissueuntargeted metabolomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Center of Respiratory and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
  • Clinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
  • Department of Thoracic Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.

ORCID-Profile: Dewei Li

Förderung

  • Regional Collaborative Innovation Special Project - Science and Technology Aid Xinjiang Program
  • The National Key Clinical Specialty of the People’s Hospital of Xinjiang Uygur Autonomous Region

Zitieren

APA

Li, D., Yang, S., Zhang, L., Dong, L., Sailai, Y., Yao, L., Jin, C., & Wei, X. (2026). Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261470635

Vancouver

Li D, Yang S, Zhang L, Dong L, Sailai Y, Yao L, et al. Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261470635

BibTeX
@article{Li2026,
  author = {Li, Dewei and Yang, Shuting and Zhang, Ling and Dong, Lingling and Sailai, Yueeryeti and Yao, Limin and Jin, Chengyu and Wei, Xuemei},
  title = {Metabolomic Characteristics of Patients With Non-Small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-Control Study},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261470635}
}
Kostenlos starten →